Stephen E. Arnold: Palantir Valuation Resembles a Unicorn on Steriods

Commercial Intelligence
Stephen E. Arnold
Stephen E. Arnold

Palantir: A Unicorn on Steroids

Whoa. I read “Palantir Valued At $20 Billion In New Funding Round.” Palantir is not exactly pumping out the marketing collateral. The company is making sales to those who want to squeeze “nuggets” from the hydraulic flow of digital information. What’s remarkable is that the company is selling into a sector which wants to buy, yet Palantir continues to collect money from funding sources.

Is the company in the business of processing data or in the business of making presentations to venture types with open checkbooks?

Read full article.

Financial Liberty at Risk-728x90